Clinical Trial Update: A Study Assessing the Safety and Utility of PINPOINT® Near Infrared Fluorescence Imaging in the Identification of Lymph Nodes in Patients With Uterine and Cervical Malignancies Who Are Undergoing Lymph Node Mapping [NA]

View source ↗

Summary

A completed clinical trial evaluating PINPOINT near-infrared fluorescence imaging for identifying lymph nodes during mapping in uterine and cervical malignancie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Endometrial Cancer
• Uterine Cancer

Drugs mentioned

• PINPOINT

Snippet

Sponsor: Novadaq Technologies ULC, now a part of Stryker | Conditions: Endometrial Cancer, Uterine Cancer | NA | Status: COMPLETED | Results posted: 2019-03-25